Medpace reports Q3 2025 earnings; press release unavailable for detail extraction

Medpace Holdings, Inc.

2025-Q3 EPS reported $10.64 revenue$1,821,784,000

Issued press release on October 22, 2025 announcing financial results for three and nine months ended September 30, 2025.
Press release furnished as Exhibit 99.1 but text not provided in this filing excerpt.
Results posted on company website; no specific revenue or EPS figures can be verified from given data.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.